GKB Ophthalmics Limited

GKB Ophthalmics Limited

GKB.BO
GKB Ophthalmics LimitedIN flagBombay Stock Exchange
60.35
INR
-2.76
- -
304.20MMarket Cap

Total Valuation

GKB Ophthalmics Limited carries a market capitalization of 304.20M, placing it among publicly traded companies globally. Its enterprise value stands at 342.41M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap304.20M
Enterprise Value342.41M

Share Statistics

GKB Ophthalmics Limited currently has 5.04M shares outstanding.

Shares Outstanding5.04M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

GKB Ophthalmics Limited trades at a trailing price-to-earnings ratio of 21.77. The price-to-sales ratio is 0.18, and the price-to-book ratio stands at 5.26.

PE Ratio21.77
PS Ratio0.18
PB Ratio5.26
P/TBV Ratio0.48
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, GKB Ophthalmics Limited trades at an EV/EBITDA multiple of 6.73 and an EV/FCF ratio of 13.13. The EV/Sales ratio of 0.23 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 6.73 provides insight into valuation relative to core operating earnings.

EV / Sales0.23
EV / EBITDA6.73
EV / EBIT6.73
EV / FCF13.13

Financial Position

GKB Ophthalmics Limited maintains a current ratio of 1.52, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 21.23, indicating elevated leverage, while an interest coverage ratio of 1.90 demonstrates limited ability to service its debt obligations.

Current Ratio1.52
Quick Ratio0.08
Debt / Equity21.23
Debt / EBITDA2.29
Interest Coverage1.90

Financial Efficiency

GKB Ophthalmics Limited posts a return on equity of 7.48 and a return on invested capital of 7.47.

Return on Equity (ROE)7.48
Return on Assets (ROA)0.95
Return on Invested Capital (ROIC)7.47
Return on Capital Employed (ROCE)6.19
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.01

Taxes

Over the trailing twelve months, GKB Ophthalmics Limited has paid 766,000.00 in income taxes, reflecting an effective tax rate of 2.47.

Income Tax766,000.00
Effective Tax Rate2.47

Stock Price Statistics

GKB Ophthalmics Limited's stock has declined approximately -19.45816% over the past 52 weeks. The 50-day moving average sits at 64.53, while the 200-day moving average is 60.74.

Beta (5Y)N/A
52-Week Price Change-19.45816%
50-Day Moving Average64.53
200-Day Moving Average60.74
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, GKB Ophthalmics Limited generated 1.49B in revenue and converted that into 12.19M in net income, yielding earnings per share of 5.99. EBITDA reached 50.86M, while operating income came in at 50.86M.

Revenue1.49B
Gross Profit436.67M
Operating Income50.86M
Pretax Income31.04M
Net Income12.19M
EBITDA50.86M
EBIT50.86M
Earnings Per Share (EPS)5.99

Balance Sheet

GKB Ophthalmics Limited holds 59.98M in cash and equivalents against 116.55M in total debt, resulting in a net debt position of 89.88M. Total book value stands at 50.41M, with working capital of 367.73M providing operational flexibility.

Cash & Cash Equivalents59.98M
Total Debt116.55M
Net Debt89.88M
Equity (Book Value)50.41M
Book Value Per Share9.98
Working Capital367.73M

Margins

GKB Ophthalmics Limited operates with a gross margin of 29.29, reflecting its pricing power and cost economics. The operating margin of 3.41 and net profit margin of 0.82 provide insight into operational efficiency.

Gross Margin29.29
Operating Margin3.41
Pretax Margin2.08
Profit Margin0.82
EBITDA Margin3.41

Scores

GKB Ophthalmics Limited posts an Altman Z-Score of 1.80, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.80